Contrast-Enhanced Ultrasound Market Snapshot (2023 to 2033)

The anticipated size of the contrast-enhanced ultrasound market in 2022 was US$ 2,700 million and is estimated to be US$ 5,243.3 million in 2023. Immediate rise in the number of performances of lung ultrasonography procedures has raised the demand for this process. Future Market Insights has mentioned in its reports that the contrast-enhanced ultrasound market will expand at a CAGR of 5.8% between 2023 and 2033, totaling around US$ 9,214.3 million by 2033.

Contrast-enhanced ultrasound (CEUS) is referred to the application of traditional medical sonography to ultrasound contrast medium. Ultrasound contrast agents rely on the different ways in which sound waves are reflected from interfaces between substances and this may be the surface of a bubble or a more complex structure.

North America is considered to be a dominant region for the Contrast-Enhanced Ultrasound Market, owing to the rising prevalence of lifestyle-associated chronic diseases and the high adoption of ultrasound modality in general diagnostics. The factor that is expected to hinder the growth of the contrast-enhanced ultrasound market during the forecast period includes the side effects and allergic reactions associated with contrast agents.

Attribute Details
Projected Forecast Value (2022) US$ 2,700 million
Projected Forecast Value (2023) US$ 5,243.3 million
Projected Forecast Value (2033) US$ 9,214.3 million
Growth rate 5.80% CAGR
Forecast period 2023 to 2033

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Contrast-Enhanced Ultrasound Market Historical Analysis (2017 to 2022) Vs. Forecast Outlook (2023 to 2033)

The global contrast-enhanced ultrasound market grew at a CAGR of 4.7% between 2017 and 2022. Growth forecasts remain optimistic, with the market predicted to exhibit a CAGR of 5.8% between 2023 and 2033.

Major factor that is expected to propel the growth of the contrast-enhanced ultrasound market during the forecast period includes the rising incidence of cardiovascular and gastrointestinal diseases.

Which are Some Prominent Drivers Spearheading Contrast-Enhanced Ultrasound Market Growth?

Introduction of Affordable Contrast Agents

Major factors that are expected to drive the growth of the contrast-enhanced ultrasound market during the forecast period include the introduction of affordable contrast agents, contrast imaging modes becoming an integral feature of ultrasound systems, and increasing ultrasound procedural volume.

Cost-Efficient, Radiation-Free, and Patient-Friendly than Other Technologies

Contrast-enhanced ultrasound (CEUS) is more cost-efficient, radiation-free, and patient-friendly than other technologies as this is another major factor that is anticipated to fuel market growth.

Immediate Increase in the Number of Lung Ultrasonography Procedures

Sudden increase in the number of lung ultrasonography procedures performed has increased the demand for this process. Rising incidence of cardiovascular and gastrointestinal diseases is expected to spur the growth of the contrast-enhanced ultrasound market during the forecast period.

Rise in the prevelance for CVDs, Liver Lesions, Kidney Lesions, Gastrointestinal Diseases, and Vascular Diseases

Increasing prevalence of CVDs, liver lesions, kidney lesions, gastrointestinal diseases, and vascular diseases globally is anticipated to boost the demand for CEUS services as these are major areas of clinical application of contrast-enhanced ultrasound systems.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Challenges Faced by the Contrast-Enhanced Ultrasound Industry?

Side Effects and Allergic Reactions Associated with Contrast Agents

Major factor that is expected to hamper the growth of the contrast-enhanced ultrasound market during the forecast period includes the side effects and allergic reactions associated with contrast agents, which will obstruct the market growth, and will further challenge the growth of the contrast-enhanced ultrasound market.

Region-wise Analysis

How is North America emerging as an Opportunistic Contrast-Enhanced Ultrasound Market?

Rising Prevalence of Lifestyle-Associated Chronic Diseases and the High Adoption of Ultrasound Modality in General Diagnostics.

North America dominates the market and is expected to continue its stronghold for a few more years with a market share of 36.0%, attributed to the rising prevalence of lifestyle-associated chronic diseases and the high adoption of ultrasound modality in general diagnostics where the United States is expected to hold a major share in the market of 52.4%. The North American contrast-enhanced ultrasound market is expected to expand at a 5% CAGR during the forecast period.

How is Asia Pacific Contributing to the Growth of the Contrast-Enhanced Ultrasound Market?

Rapid Growth in the Geriatric Population and Improvement of Healthcare Facilities for Treating Diseases

Future Market Insights says that Asia Pacific is anticipated to witness growth at a lucrative rate over the forecast period, owing to the rapidly growing geriatric population and improving healthcare facilities for treating diseases where Japan shares a value of 7.4%.

Blooming medical tourism in Asia Pacific economies is also expected to augment the market growth in the region. Prospering medical tourism in developing countries such as India growing at a CAGR of 6.9%, Australia at a CAGR of 5.2%, and the Chinese market at 7.7% which further boosts the demand for world-class healthcare services. Some major market players are strategizing to increase their presence in these regions and offer products at competitive prices, which in turn is anticipated to augment the market growth.

How is the European Market Raising its Sales?

High Demand for Technologically Advanced Medical Devices

High demand for technologically advanced medical devices in Europe is another major factor that is expected to spur the growth of the contrast-enhanced ultrasound market in the region during the forecast period with a market share of 28.0%.

United Kingdom and Germany are said to hold an important part in this region where Germany holds a market share of 7.0% and the United Kingdom is said to grow at a CAGR of 5.1%.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Comparative Analysis of Adjacent Markets

Contrast-Enhanced Ultrasound Market:

Attributes Contrast-Enhanced Ultrasound Market
CAGR (2023 to 2033) 5.80%
Market Value 2023 US$ 5,243.3 million
Growth Factor Introduction of affordable contrast agents, contrast imaging modes becoming an integral feature of ultrasound systems
Future Opportunities Rising incidence of cardiovascular and gastrointestinal diseases is expected to spur the growth of the contrast-enhanced ultrasound market
Market trends Increasing prevalence of CVDs, liver lesions, kidney lesions, gastrointestinal diseases, and vascular diseases globally

Cardiovascular Ultrasound Market:

Attributes Cardiovascular Ultrasound Market
CAGR (2023 to 2033) 7.2%
Market Value 2023 US$ 5,723.8 million
Growth Factor Rise in the demand for cardiovascular ultrasound (CVUS) procedures during the percutaneous coronary intervention
Future Opportunities Increase in the adoption of cardiovascular ultrasound (CVUS) systems in hospitals and diagnostic centers
Market trends increasing prevalence of chronic diseases, such as heart attack, coronary artery disease, and myocardial infarction, is one of the high-impact rendering factors contributing to the increased usage of intravascular ultrasonography (CVUS) devices.

Breast Ultrasound Market:

Attributes Breast Ultrasound Market
CAGR (2023 to 2033) 13.9%
Market Value 2023 US$ 6,219.2 million
Growth Factor Technological advancements for the novel breast ultrasound systems
Future Opportunities Availability of advanced technologies for dense breast tissue scanning
Market trends Research and Development activities bolster the development of breast ultrasound market

Category-wise Analysis

Which Type Holds a Major Portion in the Market?

Targeted Type Holds a Major Portion in the Market

Targeted type holds a market share of 59.0% where molecular imaging has the potential for obtaining tissue expression profiles in a volumetric manner without invasive tissue sampling procedures and without the limitation of potential sampling errors from biopsies.

Which End-user Holds a Dominant Position in the Market?

Hospitals are said to Dominate the Market Region

Hospital segment dominates the market and is projected for a revenue share of 39% where the rise in the number of emergency visits with medical conditions, like abdominal pain, thoracic trauma, and cardiac complications, has led to a rise in demand in hospitals.

Which Application Demand is Said to be Faring?

Demand for Echocardiography is said to be Faring Well

Echocardiography shares a major portion of the market with a value of 60.13% where doctors use echocardiograms for helping them to diagnose heart problems, like damaged cardiac tissue, chamber enlargement, stiffening of the heart muscle, blood clots in the heart, fluid around the heart, etc.

Competitive Analysis

Some of the prominent players in the global market are-

  • Trivitron Healthcare
  • Bracco Diagnostic Inc.
  • Koninklijke Philips N.V.
  • B.K. Medical Holding Company, Inc.
  • Lantheus Medical Imaging, Inc.
  • GE Healthcare
  • Daiichi Sankyo Company, Limited
  • Bristol-Myers Squibb Company
  • Acusphere, Inc.
  • Siemens Healthcare GmbH

Some of the important developments of the key players in the market are:

  • In July 2023, Siemens Healthcare Diagnostics and its subsidiaries are currently working on the development of 15 products that fall under the In Vitro Diagnostics, Cardiovascular Devices, and Diagnostic Imaging markets. GlobalData’s report Siemens Healthcare Diagnostics Medical Device Development provides an overview of the company’s pipeline landscape and offers a detailed analysis of its products in development.
  • In July 2023, Trivitron Healthcare and its subsidiaries are currently working on the development of 12 products that fall under the In Vitro Diagnostics, Cardiovascular Devices, and Diabetes Care Devices markets. GlobalData’s report Trivitron Healthcare Medical Device Development provides an overview of the company’s pipeline landscape and offers detailed analysis of its products in development.

Scope of Report

Attribute Details
Growth Rate CAGR of 5.8% from 2023 to 2033
Market value in 2023 US$ 5,243.3 million
Market value in 2033 US$ 9,214.3 million
Base Year for Estimation 2022
Historical Data 2017 to 2022
Forecast Period 2023 to 2033
Quantitative Units US$ million for Value and CAGR from 2023 to 2033
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered By Type, By Application, By Region
Regions Covered North America; Latin America; Western Europe; Eastern Europe; South Asia and Pacific; East Asia; Middle East & Africa
Key Countries Profiled United States, Canada, Brazil, Mexico, Germany, United Kingdom, France, Spain, Italy, Poland, Russia, Czech Republic, Romania, India, Bangladesh, Australia, New Zealand, China, Japan, South Korea, GCC Countries, South Africa, Israel
Key Companies Profiled Trivitron Healthcare; Bracco Diagnostic Inc.; Koninklijke Philips N.V.; B.K. Medical Holding Company, Inc.; Lantheus Medical Imaging, Inc.; GE Healthcare; Daiichi Sankyo Company, Limited; Bristol-Myers Squibb Company; Acusphere, Inc.; Siemens Healthcare GmbH
Customization & Pricing Available on Request

Key Segments Profiled in the Contrast-Enhanced Ultrasound Industry Survey

Type:

  • Non-Targeted
  • Targeted

Application:

  • Hepatic
  • Echocardiography
  • Cerebrovascular
  • Thyroid & Parathyroid
  • Gallbladder & Biliary Tree
  • Renal
  • Prostate
  • Pancreatic
  • Vascular
  • Lymphatic
  • Trauma
  • Others

Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa

Frequently Asked Questions

What is the projected CAGR of the Contrast-Enhanced Ultrasound Market by 2033?

The projected CAGR of the contrast-enhanced ultrasound market by 2033 is 5.80%.

What is the projected Contrast-Enhanced Ultrasound Market value for 2033?

The projected market value for 2033 is US$ 9,214.3 million.

What is the Current Market Valuation of the Contrast-Enhanced Ultrasound Market?

The market is estimated to secure a valuation of US$ 5,243.3 million in 2023.

Which Region Holds a Significant Share of the Contrast-Enhanced Ultrasound Market?

North America holds a significant share of the contrast-enhanced ultrasound market.

Why is the North American market growing remarkably fast in the Contrast-Enhanced Ultrasound Market?

The North American market is growing due to the increasing prevalence of chronic diseases.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2017 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2023 to 2033

        5.3.1. Non-Targeted

        5.3.2. Targeted

    5.4. Y-o-Y Growth Trend Analysis By Type, 2017 to 2022

    5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033

6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2017 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033

        6.3.1. Hepatic

        6.3.2. Echocardiography

        6.3.3. Cerebrovascular

        6.3.4. Thyroid & Parathyroid

        6.3.5. Gallbladder & Biliary Tree

        6.3.6. Renal

        6.3.7. Prostate

        6.3.8. Pancreatic

        6.3.9. Vascular

        6.3.10. Lymphatic

        6.3.11. Trauma

        6.3.12. Others

    6.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2022

    6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033

7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2022

    7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Western Europe

        7.3.4. Eastern Europe

        7.3.5. South Asia and Pacific

        7.3.6. East Asia

        7.3.7. Middle East and Africa

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        8.2.1. By Country

            8.2.1.1. The USA

            8.2.1.2. Canada

        8.2.2. By Type

        8.2.3. By Application

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Type

        8.3.3. By Application

    8.4. Key Takeaways

9. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Type

        9.2.3. By Application

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Type

        9.3.3. By Application

    9.4. Key Takeaways

10. Western Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. United Kingdom

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Western Europe

        10.2.2. By Type

        10.2.3. By Application

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Type

        10.3.3. By Application

    10.4. Key Takeaways

11. Eastern Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Poland

            11.2.1.2. Russia

            11.2.1.3. Czech Republic

            11.2.1.4. Romania

            11.2.1.5. Rest of Eastern Europe

        11.2.2. By Type

        11.2.3. By Application

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Type

        11.3.3. By Application

    11.4. Key Takeaways

12. South Asia and Pacific Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Bangladesh

            12.2.1.3. Australia

            12.2.1.4. New Zealand

            12.2.1.5. Rest of South Asia and Pacific

        12.2.2. By Type

        12.2.3. By Application

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Type

        12.3.3. By Application

    12.4. Key Takeaways

13. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Type

        13.2.3. By Application

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Type

        13.3.3. By Application

    13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of MEA

        14.2.2. By Type

        14.2.3. By Application

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Type

        14.3.3. By Application

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. USA

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2022

            15.1.2.1. By Type

            15.1.2.2. By Application

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2022

            15.2.2.1. By Type

            15.2.2.2. By Application

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2022

            15.3.2.1. By Type

            15.3.2.2. By Application

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2022

            15.4.2.1. By Type

            15.4.2.2. By Application

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2022

            15.5.2.1. By Type

            15.5.2.2. By Application

    15.6. United Kingdom

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2022

            15.6.2.1. By Type

            15.6.2.2. By Application

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2022

            15.7.2.1. By Type

            15.7.2.2. By Application

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2022

            15.8.2.1. By Type

            15.8.2.2. By Application

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2022

            15.9.2.1. By Type

            15.9.2.2. By Application

    15.10. Poland

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2022

            15.10.2.1. By Type

            15.10.2.2. By Application

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2022

            15.11.2.1. By Type

            15.11.2.2. By Application

    15.12. Czech Republic

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2022

            15.12.2.1. By Type

            15.12.2.2. By Application

    15.13. Romania

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2022

            15.13.2.1. By Type

            15.13.2.2. By Application

    15.14. India

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2022

            15.14.2.1. By Type

            15.14.2.2. By Application

    15.15. Bangladesh

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2022

            15.15.2.1. By Type

            15.15.2.2. By Application

    15.16. Australia

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2022

            15.16.2.1. By Type

            15.16.2.2. By Application

    15.17. New Zealand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2022

            15.17.2.1. By Type

            15.17.2.2. By Application

    15.18. China

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2022

            15.18.2.1. By Type

            15.18.2.2. By Application

    15.19. Japan

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2022

            15.19.2.1. By Type

            15.19.2.2. By Application

    15.20. South Korea

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2022

            15.20.2.1. By Type

            15.20.2.2. By Application

    15.21. GCC Countries

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2022

            15.21.2.1. By Type

            15.21.2.2. By Application

    15.22. South Africa

        15.22.1. Pricing Analysis

        15.22.2. Market Share Analysis, 2022

            15.22.2.1. By Type

            15.22.2.2. By Application

    15.23. Israel

        15.23.1. Pricing Analysis

        15.23.2. Market Share Analysis, 2022

            15.23.2.1. By Type

            15.23.2.2. By Application

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Type

        16.3.3. By Application

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Trivitron Healthcare

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

        17.1.2. Bracco Diagnostic Inc.

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

        17.1.3. Koninklijke Philips N.V.

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

        17.1.4. B.K. Medical Holding Company, Inc.

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

        17.1.5. Lantheus Medical Imaging, Inc.

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

        17.1.6. GE Healthcare

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

        17.1.7. Daiichi Sankyo Company, Limited

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

        17.1.8. Bristol-Myers Squibb Company

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

        17.1.9. Acusphere, Inc.

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

        17.1.10. Siemens Healthcare GmbH

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Recommendations

Healthcare

Veterinary Ultrasound Scanner Market

January 2022

REP-GB-3356

November 2023

247 pages

Healthcare

Cardiac Ultrasound Systems Market

September 2021

REP-GB-7692

June 2023

324 pages

Healthcare

Ultrasound Devices Market

November 2022

REP-GB-15794

250 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Contrast-Enhanced Ultrasound Market